Skip to content
Back to XENE

Xenon Pharmaceuticals Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
28
Purchases
2
Sales
26
Purchase value
$1.68M
Sale value
$21.97M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Thomas Patrick KellyChief Financial Officer
4
Filed Oct 1, 2026Period of report Sep 30, 20260001193125-26-410001
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseSep 30, 2026
Common Shares15,000$37.316$559.74K15,000Direct
Open on SEC EDGAR
IAN MortimerDirector · PRESIDENT & CEO
4
Filed Oct 1, 2026Period of report Sep 30, 20260001193125-26-409999
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseSep 30, 2026
Common Shares30,000$37.38$1.12M49,923Direct
Open on SEC EDGAR
Christopher John KenneyChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Aug 31, 2026Period of report Aug 28, 20260001193125-26-377309
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 28, 2026
Common SharesF1F26,368$60.1673$383.15K702Direct
SaleAug 28, 2026
Common SharesF1F3F4700$60.9766$42.68K2Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.
  2. F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $59.79 to $60.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $60.81 to $61.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4The number of shares beneficially owned following the reported transactions reflects an upward adjustment of one share from the reporting person's previous Form 4 filed on March 13, 2026, based on updated tax withholding calculations for the transactions described on the previously filed Form 4.
Open on SEC EDGAR
Steven GannonDirector
4
Filed Aug 13, 2026Period of report Aug 11, 20260001193125-26-349351
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 11, 2026
Common SharesF110,000$64.055$640.55K1,870Direct
Filing footnotes · 1
  1. F1The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $64.0517 to $64.078, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open on SEC EDGAR
Gary PatouDirector
4Rule 10b5-1 plan disclosed
Filed Jun 8, 2026Period of report Jun 5, 20260001193125-26-262672
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 5, 2026
Common SharesF11,322$53.14$70.25K24,896Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 17, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025.
  2. F2By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou.
Open on SEC EDGAR
Gillian CannonDirector
4Rule 10b5-1 plan disclosed
Filed Jun 8, 2026Period of report Jun 5, 20260001193125-26-262671
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 5, 2026
Common SharesF11,190$53.14$63.24K1,455Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025.
Open on SEC EDGAR
Christopher John KenneyChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Mar 13, 2026Period of report Mar 12, 20260001193125-26-106727
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common SharesF21,410$55.225$77.87K7,069Direct
Filing footnotes · 2
  1. F1Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025.
Open on SEC EDGAR
Andrea DiFabioChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Mar 13, 2026Period of report Mar 12, 20260001193125-26-106726
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common SharesF21,342$55.225$74.11K7,301Direct
Filing footnotes · 2
  1. F1Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025.
Open on SEC EDGAR
IAN MortimerDirector · PRESIDENT & CEO
4Rule 10b5-1 plan disclosed
Filed Mar 13, 2026Period of report Mar 12, 20260001193125-26-106724
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common SharesF27,308$55.225$403.58K19,923Direct
Filing footnotes · 2
  1. F1Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025.
Open on SEC EDGAR
Christopher John KenneyChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Mar 11, 2026Period of report Mar 9, 20260001193125-26-102669
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 10, 2026
Common SharesF22,771$60.108$166.56K4,729Direct
Filing footnotes · 2
  1. F1Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.
Open on SEC EDGAR
Andrea DiFabioChief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Mar 11, 2026Period of report Mar 9, 20260001193125-26-102667
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 10, 2026
Common SharesF22,607$60.108$156.70K4,893Direct
Filing footnotes · 2
  1. F1Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.
Open on SEC EDGAR
IAN MortimerDirector · PRESIDENT & CEO
4Rule 10b5-1 plan disclosed
Filed Mar 11, 2026Period of report Mar 9, 20260001193125-26-102666
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 10, 2026
Common SharesF1211,269$60.108$677.36K14,731Direct
SaleMar 9, 2026
Common SharesF1F221,791$58.81$1.28M59,209Direct
SaleMar 9, 2026
Common SharesF1F331,694$59.88$1.90M27,515Direct
SaleMar 9, 2026
Common SharesF1F421,515$60.49$1.30M6,000Direct
SaleMar 9, 2026
Common SharesF1F512,479$59.50$742.50K18,521Direct
SaleMar 9, 2026
Common SharesF1F610,072$60.47$609.05K8,449Direct
SaleMar 9, 2026
Common SharesF1F72,449$61.26$150.03K6,000Direct
SaleMar 9, 2026
Common SharesF1F843,348$59.26$2.57M72,652Direct
SaleMar 9, 2026
Common SharesF1F961,652$60.08$3.70M6,000Direct
SaleMar 9, 2026
Common SharesF1F1065,000$62.06$4.03M6,000Direct
Filing footnotes · 13
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.
  2. F10The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F11Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.
  4. F12The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.
  5. F13The shares subject to this option are fully vested and exercisable.
  6. F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $58.16 to $59.1425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  7. F3The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.16 to $60.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  8. F4The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $60.16 to $61.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  9. F5The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.03 to $60.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  10. F6The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $60.05 to $61.035, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  11. F7The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $61.055 to $61.555, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  12. F8The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $58.745 to $59.735, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  13. F9The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.75 to $60.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open on SEC EDGAR
IAN MortimerDirector · PRESIDENT & CEO
4Rule 10b5-1 plan disclosed
Filed Jan 2, 2026Period of report Jan 2, 20260001193125-26-001172
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 2, 2026
Common SharesF1F237,938$44.40$1.68M8,062Direct
SaleJan 2, 2026
Common SharesF1F32,062$44.93$92.65K6,000Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.
  2. F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $43.91 to $44.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $44.91 to $45.125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4The shares subject to the option are fully vested and exercisable.
Open on SEC EDGAR
IAN MortimerDirector · PRESIDENT & CEO
4Rule 10b5-1 plan disclosed
Filed Dec 9, 2025Period of report Dec 5, 20250001193125-25-313147
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 8, 2025
Common SharesF1F38,820$45.59$402.10K8,010Direct
SaleDec 8, 2025
Common SharesF1F42,010$46.32$93.10K6,000Direct
SaleDec 5, 2025
Common SharesF1F214,375$45.03$647.31K16,830Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.
  2. F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $45.00 to $45.135, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $45.02 to $46.013, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.02 to $46.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open on SEC EDGAR
IAN MortimerDirector · PRESIDENT & CEO
4Rule 10b5-1 plan disclosed
Filed Dec 3, 2025Period of report Nov 28, 20250001193125-25-307211
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 28, 2025
Common SharesF197$45.01$4.37K31,205Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.